ArticlePharmaceutics2021

Complementary Nucleobase Interactions Drive Co-Assembly of Drugs and Nanocarriers for Selective Cancer Chemotherapy.

Fasih Bintang Ilhami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.